Mantex (Mantex) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
11 Nov, 2025Executive summary
Net sales for Q3 2025 reached 1,720 tkr, a significant increase from 342 tkr in Q3 2024, driven by a one-time sale of a Biomass Analyzer unit.
EBIT improved to -2,806 tkr from -7,653 tkr year-over-year, reflecting cost-saving measures.
Cash flow from operating activities was positive at 404 tkr, compared to -5,366 tkr in Q3 2024.
New CEO Gustav Melin, previously a board member and bioenergy expert, was appointed in September 2025.
Divestment of the stake in Andritz Technologies AB provided immediate liquidity and future royalty income.
Financial highlights
Q3 2025 net sales: 1,720 tkr (Q3 2024: 342 tkr); nine months 2025: 2,534 tkr (2024: 2,233 tkr).
EBIT for Q3 2025: -2,806 tkr (Q3 2024: -7,653 tkr); nine months 2025: -12,471 tkr (2024: -18,792 tkr).
Result per share for Q3: -5.69 SEK (Q3 2024: -0.03 SEK); nine months: -10.91 SEK (2024: -0.08 SEK), impacted by a reverse split.
Equity at period end: 9,213 tkr (2024: 6,200 tkr).
Outlook and guidance
Expansion of product certification to additional wood assortments expected in Q1 2026, enabling broader market access.
Ongoing focus on cost reduction and operational improvements under new leadership.
International sales expansion planned for 2026 and beyond.
Latest events from Mantex
- Q4 2025 saw improved EBIT and cash flow, new product delivery, and strengthened financing.Mantex
Q4 202517 Feb 2026 - EBIT loss narrowed and cost savings realized as focus shifts to Biomass Analyzer 2 launch.Mantex
Q2 202517 Jul 2025 - Revenue declined and losses widened, but FlowScanner FS3000 delivery marks a key milestone.Mantex
Q2 202413 Jun 2025 - Sales fell and losses deepened as Mantex prioritized product development and future growth.Mantex
Q3 202413 Jun 2025 - Tech breakthrough opens bioenergy market, but Q1 revenue drops and losses deepen.Mantex
Q1 20256 Jun 2025 - Technical breakthrough and new contracts set the stage for future growth despite weak 2024.Mantex
Q4 20245 Jun 2025